Gonadal status and physical performance in older men

Aging Male

Volumn 14, Issue 1, 2011, Pages 42-47

  Maggio, Marcello ^a,b   Ceda, Gian Paolo ^a,b   Lauretani, Fulvio ^b   Bandinelli, Stefania ^c   Metter, Earl Jeffrey ^d   Guralnik, Jack M ^e   Basaria, Shehzad ^f   Cattabiani, Chiara ^a   Luci, Michele ^a   Dall'Aglio, Elisabetta ^a   Vignali, Alessandro ^a   Volpi, Riccardo ^a   Valenti, Giorgio ^a   Ferrucci, Luigi ^d  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

^c Azienda Sanitaria di Firenze   (Italy)

^d Clinical Research Branch   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

older men; physical performance; Testosterone

Indexed keywords

HEMOGLOBIN; TESTOSTERONE;

AGE; AGED; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; CROSS SECTIONAL MUSCLE AREA; DISEASE ASSOCIATION; DISEASE SEVERITY; FUNCTIONAL STATUS; GASTROCNEMIUS MUSCLE; GONAD; GRIP STRENGTH; HAND GRIP; HUMAN; HYPOGONADISM; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; SHORT PHYSICAL PERFORMANCE BATTERY; TESTOSTERONE BLOOD LEVEL; WALKING;

AGE FACTORS; AGED; AGING; ANDROGENS; EXERCISE TEST; HEALTH STATUS; HEALTH STATUS INDICATORS; HEMOGLOBINS; HUMANS; HYPOGONADISM; INFLAMMATION; INTERLEUKIN-6; ITALY; LINEAR MODELS; MALE; MEN'S HEALTH; MOTOR ACTIVITY; MUSCLE STRENGTH; MUSCLE, SKELETAL; REFERENCE VALUES; TASK PERFORMANCE AND ANALYSIS; TESTOSTERONE;

EID: 79751469516     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685538.2010.518179     Document Type: Article

References (27)

1. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724-731. (Pubitemid 32207487)
2. Valenti G, Bossoni S, Giustina A, Maugeri D, Motta M, Vigna GB, Fellin R, Corica F, Corsonello A, Paolisso G, et al. Consensus Document on substitution therapy with testosterone in hypoandrogenic elderly men. Aging Clin Exp Res 2002;14:439-464. (Pubitemid 36410428)
3. Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 2002;5:74-86.
4. Petak SM, Nankin HR, Spark RF, Swerdloff RS, Rodriguez- Rigau LJ. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients - 2002 update. Endocr Pract 2002;8:440-456.
5. Practice Committee of the American Society for Reproductive Medicine. Treatment of androgen deficiency in the aging male. Fertil Steril 2004;81:1437-1440.
6. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006;91:1995-2010. (Pubitemid 43854972)
7. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, et al. ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2009;12:5-12.
8. Ferrucci L, Maggio M, Bandinelli S, Basaria S, Lauretani F, Ble A, Valenti G, Ershler WB, Guralnik JM, Longo DL. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med 2006;166:1380-1388. (Pubitemid 44036350)
9. Chaves PH. Functional outcomes of anemia in older adults. Semin Hematol 2008;45:255-260.
10. Orwoll E, Lambert LC, Marshall LM, Blank J, Barrett- Connor E, Cauley J, Ensrud K, Cummings SR; Osteoporotic Fractures in Men Study Group. Endogenous testosterone levels, physical performance, and fall risk in older men. Arch Intern Med 2006;166:2124-2131. (Pubitemid 44631401)
11. Araujo AB, Travison TG, Bhasin S, Esche GR, Williams RE, Clark RV, McKinlay JB. Association between testosterone and estradiol and age-related decline in physical function in a diverse sample of men. J Am Geriatr Soc 2008;56:2000-2008.
12. Bylow K, Mohile SG, Stadler WM, Dale W. Does androgendeprivation therapy accelerate the development of frailty in older men with prostate cancer? A conceptual review. Cancer 2007;110:2604-2613. (Pubitemid 350250329)
13. Basaria S, Lieb J II, Tang AM, DeWeese T, Carducci M, Eisenberger M, Dobs AS. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol (Oxf) 2002;56:779-786. (Pubitemid 34785910)
14. Clay CA, Perera S, Wagner JM, Miller ME, Nelson JB, Greenspan SL. Physical function in men with prostate cancer on androgen deprivation therapy. Phys Ther 2007;87:1325-1333. (Pubitemid 47584278)
15. Ferrucci L, Bandinelli S, Benvenuti E, Di Iorio A, Macchi C, Harris TB, Guralnik JM. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 2000;48:1618-1625.
16. Cesari M, Pahor M, Lauretani F, Zamboni V, Bandinelli S, Bernabei R, Guralnik JM, Ferrucci L. Skeletal muscle and mortality results from the InCHIANTI Study. J Gerontol A Biol Sci Med Sci 2009;64:377-384.
17. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49:M85-M94. (Pubitemid 24100267)
18. Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006;91:4335-4343. (Pubitemid 44833407)
19. Sih R,Morley JE, Kaiser FE, Perry HM III, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12- month randomized controlled trial. J Clin Endocrinol Metab 1997;82:1661-1667. (Pubitemid 127495166)
20. Coviello AD, Kaplan B, Lakshman KM, Chen T, Singh AB, Bhasin S. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab 2008;93:914-919. (Pubitemid 351398573)
21. Ferrando AA, Sheffield-Moore M, Yeckel CW, Gilkison C, Jiang J, Achacosa A, Lieberman SA, Tipton K, Wolfe RR, Urban RJ. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 2002;282:E601-E607. (Pubitemid 34654776)
22. Onder G, Della Vedova C, Landi F. Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia. J Nutr Health Aging 2009;13:746-756.
23. Srinivas-Shankar U, Roberts SA, Connolly MJ, O'Connell MD, Adams JE, Oldham JA, Wu FC. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab;95:639-650.
24. Ottenbacher KJ, Ottenbacher ME, Ottenbacher AJ, Acha AA, Ostir GV. Androgen treatment and muscle strength in elderly men: A meta-analysis. J Am Geriatr Soc 2006;54:1666-1673. (Pubitemid 44665204)
25. Storer TW, Woodhouse L, Magliano L, Singh AB, Dzekov C, Dzekov J, Bhasin S. Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men. J Am Geriatr Soc 2008;56:1991-1999.
26. Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 1999;107:123-136. (Pubitemid 29138849)
27. Webber SC, Porter MM, Menec VH. Mobility in older adults: a comprehensive Framework. Gerontologist 2010;50:443-450.